| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1995;60:1623-1626
© 1995 The Society of Thoracic Surgeons
Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
* Address reprint requests to Dr Pham, Division of Cardiothoracic Surgery, University of Pittsburgh School of Medicine, Suite C-700, Presbyterian University Hospital, 200 Lothrop St, Pittsburgh, PA 15213.
Background.: Prolonged nonspecific immunosuppression after solid-organ transplantation is associated with an increased risk of certain cancers. This study examined the development of solid-organ tumors after cardiac transplantation.
Methods.: Thirty-eight solid tumors were identified in 36 (5.9%) of 608 cardiac transplant recipients who survived more than 30 days. Two patients had two types of skin tumors (basal cell and squamous cell). The tumors included the following types: skin (15), lung (10), breast (1), bladder (2), larynx (2), liver (1), parotid (1), testicle (1), uterus (2), melanoma (2), and Merkel's cell (1). Four immunosuppression regimens based on cyclosporin A or FK 506 were used during this period.
Results.: There was no association between the incidence of solid tumors and the use of lympholytic therapy. After the diagnosis of tumor was made, the actuarial 2-year survival rates of recipients with skin, lung, and other solid tumors were 71%, 22%, and 23%, respectively. Eight of 10 patients with lung cancer were in stage IIIA or higher at the time of diagnosis.
Conclusion.: Skin and lung tumors are the most frequent solid tumors in heart transplant recipients. Skin tumors (except Merkel's cell carcinoma and melanoma) usually have a benign course, whereas lung and other tumors developing in cardiac transplant recipients carry a poor prognosis. Advanced disease stage at the time of diagnosis is responsible for the dismal outcome of recipients in whom solid tumors develop. Close postoperative tumor surveillance after cardiac transplantation is warranted.
This article has been cited by other articles:
|
|
 |
|
  L. J. Dupont and G. M. Verleden Noninfectious pulmonary complications after organ transplantation Pulmonary Manifestations of Systemic Diseases, June 28, 2010; 202 - 219. [Abstract] [Fulltext] [PDF]
|
|
|
|
 |
|
 J. L. Vahle, G. L. Finch, S. M. Heidel, D. N. Hovland Jr, I. Ivens, S. Parker, R. A. Ponce, C. Sachs, R. Steigerwalt, B. Short, et al. Carcinogenicity Assessments of Biotechnology-Derived Pharmaceuticals: A Review of Approved Molecules and Best Practice Recommendations Toxicol Pathol, June 1, 2010; 38(4): 522 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.-B. Hsu, C.-I. Chang, M.-K. Tsai, P.-H. Lee, N.-K. Chou, N.-H. Chi, S.-S. Wang, and S.-H. Chu Low incidence of malignancy in heart-transplant recipients in Taiwan: an update and comparison with kidney-transplant recipients Eur J Cardiothorac Surg, May 1, 2010; 37(5): 1117 - 1121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Potaris, B. Radovancevic, C. D. Thomas, I. Gregoric, A. A. Vaporciyan, S. A. Riggs, R. Radovancevic, W. K. Vaughn, and O.H. Frazier Lung Cancer After Heart Transplantation: A 17-Year Experience Ann. Thorac. Surg., March 1, 2005; 79(3): 980 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bagan, J. Assouad, P. Berna, R. Souilamas, F. Le Pimpec Barthes, and M. Riquet Immediate and Long-Term Survival After Surgery for Lung Cancer in Heart Transplant Recipients Ann. Thorac. Surg., February 1, 2005; 79(2): 438 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Ahmed, M. B. Marshall, J. C. Kucharczuk, L. R. Kaiser, and J. B. Shrager Lung Cancer in Transplant Recipients: A Single-Institution Experience Arch Surg, August 1, 2004; 139(8): 902 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Boffa, F. Luan, D. Thomas, H. Yang, V. K. Sharma, M. Lagman, and M. Suthanthiran Rapamycin Inhibits the Growth and Metastatic Progression of Non-Small Cell Lung Cancer Clin. Cancer Res., January 1, 2004; 10(1): 293 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kanitakis, L. Alhaj-Ibrahim, S. Euvrard, and A. Claudy Basal Cell Carcinomas Developing in Solid Organ Transplant Recipients: Clinicopathologic Study of 176 Cases Arch Dermatol, September 1, 2003; 139(9): 1133 - 1137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. de Perrot, D. A. Wigle, A. F. Pierre, M. S. Tsao, T. K. Waddell, T. R.J. Todd, and S. H. Keshavjee Bronchogenic carcinoma after solid organ transplantation Ann. Thorac. Surg., February 1, 2003; 75(2): 367 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Anyanwu, E. R. Townsend, N. R. Banner, M. Burke, A. Khaghani, and M. H. Yacoub Primary lung carcinoma after heart or lung transplantation: Management and outcome J. Thorac. Cardiovasc. Surg., December 1, 2002; 124(6): 1190 - 1197. [Abstract] [Full Text]
|
|
|
|
|
|
M. Rinaldi, C. Pellegrini, A. M. D'Armini, M. Aiello, M. Negri, E. Arbustini, G. Ippoliti, and M. Vigano Neoplastic disease after heart transplantation: single center experience Eur J Cardiothorac Surg, May 1, 2001; 19(5): 696 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. L. Knisely, L. A. Mastey, J. Collins, J. E. Kuhlman, and A. N. Leung Imaging of Cardiac Transplantation Complications RadioGraphics, March 1, 1999; 19(2): 321 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Fernandez-Gonzalez, A. Espana, and P. Redondo Solid Tumors After Heart Transplantation Ann. Thorac. Surg., September 1, 1996; 62(3): 943 - 944. [Full Text]
|
|
|
|
|
|
I. Penn Solid tumors in cardiac allograft recipients Ann. Thorac. Surg., December 1, 1995; 60(6): 1559 - 1560. [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
